Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 2
This trial is looking at dostarlimab by itself and with other immunotherapies. The other immunotherapies are belrestotug and GSK6097608.
It is open to people with non small cell lung cancer that has spread.
You pronounce belrestotug as bell-rest-oh-tug.
Recruitment start: 17 February 2023
Recruitment end: 31 March 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Andreas Polychronis
GlaxoSmithKline (GSK)
Last reviewed: 31 March 2025
CRUK internal database number: 19422
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
